EUVIMEDEUVIMED entdecken
Übersichtsarbeit

99mTechnetium-labeled cardiac scintigraphy for suspected amyloidosis: a review of current and future directions

Jean Michel Saad iD, Ahmed Ibrahim Ahmed iD, Yushui Han, Subha Saeed, Payam Pournazari, Mouaz H Al-Mallah iD

Heart Failure Reviews · 2022-09 · 27 (5) · 1493-1503

DOI: 10.1007/s10741-021-10174-x ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Heart Failure Reviews, online erschienen am 28.10.2021. Verfasst von Jean Michel Saad und 5 weiteren Autor:innen. Beteiligte Einrichtung: Houston Methodist Debakey Heart & Vascular Center, Houston, TX, USA. Hauptthemen laut MEDLINE: Amyloidosis, Cardiomyopathies. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 63 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiac amyloidosis (CA) is an underdiagnosed form of restrictive cardiomyopathy leading to a rapid progression into heart failure. Evaluation of CA requires a multimodality approach making use of echocardiography, cardiac magnetic imaging, and nuclear imaging. Technetium (Tc)-labeled cardiac scintigraphy has witnessed a resurgence in its application for the workup of CA. Advancements in disease-modifying therapies have fueled the rapid adoption of cardiac scintigraphy using bone tracers and the need for transformative novel studies. The goal of this review is to present diagnostic utility, currently recommended protocols, as well as a glimpse into the rapid evolution of Tc-labeled cardiac scintigraphy in the diagnosis of CA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmyloidosisCardiomyopathiesEchocardiographyHeartHumansRadionuclide ImagingTechnetium

Stichwörter der Autor:innen

ATTRAmyloidosisNuclearQuantificationSPECTScintigraphy

Substanzen

Technetium

Autor:innen und Institutionen

  • Houston Methodist Debakey Heart & Vascular Center, Houston, TX, USA.
  • Crozer Keystone Health System, Upland, PA, USA.
  • Houston Methodist Debakey Heart & Vascular Center, Houston, TX, USA. mal-mallah@houstonmethodist.org.

ORCID-Profile: Jean Michel Saad, Ahmed Ibrahim Ahmed, Mouaz H Al-Mallah

Zitieren

APA

Saad, J. M., Ahmed, A. I., Han, Y., Saeed, S., Pournazari, P., & Al-Mallah, M. H. (2022). 99mTechnetium-labeled cardiac scintigraphy for suspected amyloidosis: a review of current and future directions. Heart Failure Reviews, 27(5), 1493-1503. https://doi.org/10.1007/s10741-021-10174-x

Vancouver

Saad JM, Ahmed AI, Han Y, Saeed S, Pournazari P, Al-Mallah MH. 99mTechnetium-labeled cardiac scintigraphy for suspected amyloidosis: a review of current and future directions. Heart Failure Reviews. 2022;27(5):1493-1503. doi:10.1007/s10741-021-10174-x

BibTeX
@article{Saad2022,
  author = {Saad, Jean Michel and Ahmed, Ahmed Ibrahim and Han, Yushui and Saeed, Subha and Pournazari, Payam and Al-Mallah, Mouaz H},
  title = {99mTechnetium-labeled cardiac scintigraphy for suspected amyloidosis: a review of current and future directions},
  journal = {Heart Failure Reviews},
  year = {2022},
  volume = {27},
  number = {5},
  pages = {1493--1503},
  doi = {10.1007/s10741-021-10174-x}
}
Kostenlos starten →